Ashfield Acquires Research Partnership
Healthcare market research and insights company will become part of Ashfield Advisory.
Research Partnership (London, UK), a global healthcare market research and insights company, has been acquired by Ashfield. The company will become part of Ashfield’s advisory and consulting division, Ashfield Advisory.
Working with clients in the pharmaceutical, biotech, consumer healthcare and med tech industries, Research Partnership provides research intelligence on a global basis and throughout the entire lifecycle of products.
Colin Stanley, Global President of Ashfield Advisory, commented: “The addition of the Research Partnership team will bring a new market research and insights capabilities to our services and allows us to further diversify our geographic reach adding capacity in Asia and an increased footprint in Europe.”
Founded in 1997, Research Partnership is headquartered in London with offices in New York, Philadelphia, San Francisco, Lyon, and Singapore. It employs 220+ healthcare experts across the globe, completing projects in over 80 different therapeutic areas.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
